Posttranslational Histone Modifications and the Neurobiology of Psychosis

作者: Schahram Akbarian , Iris Cheung , Caroline Connor , Mira Jakovcevski , Yan Jiang

DOI: 10.1007/978-3-642-17426-1_1

关键词:

摘要: Schizophrenia and related major psychiatric disease is typically defined by the conspicuous absence of a defining neuropathology lack straightforward identifiable genetic factors in majority affected individuals. On other hand, there increasing evidence that distinct set RNAs, many which encode proteins critical importance for myelin regulation oligodendrocyte function, or GABAergic inhibitory glutamatergic excitatory neurotransmission are expressed at altered levels diseased brain. This chapter explores mechanisms epigenetic regulators gene expression, including covalent histone modifications, could contribute to dysregulation expression schizophrenia. There also discussion on methodological scientific limitations histone-focused approaches, as it pertains human (postmortem) brain, well brief remarks topic heritability chromatin structures potentially The authors predict study both candidate loci genome-wide, will become an important tool investigation abnormalities potential brains subjects psychosis spectrum.

参考文章(147)
Raj Kumar, Oksana Holian, Brian Cook, Pash Roshani, Inhibition of Rat Brain Protein Kinase C by Lipid Soluble Psychotropics Neurochemical Research. ,vol. 22, pp. 1- 10 ,(1997) , 10.1023/A:1027332000569
M. V. Simonini, L. M. Camargo, E. Dong, E. Maloku, M. Veldic, E. Costa, A. Guidotti, The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 1587- 1592 ,(2006) , 10.1073/PNAS.0510341103
Yanming Wang, Wolfgang Fischle, Wang Cheung, Steven Jacobs, Sepideh Khorasanizadeh, C. David Allis, Beyond the double helix: writing and reading the histone code. Novartis Foundation Symposium. ,vol. 259, pp. 3- 17 ,(2004) , 10.1002/0470862637.CH2
Alan P. Wolffe, New insights into chromatin function in transcriptional control. The FASEB Journal. ,vol. 6, pp. 3354- 3361 ,(1992) , 10.1096/FASEBJ.6.15.1464369
Frank A. Middleton, Karoly Mirnics, Joseph N. Pierri, David A. Lewis, Pat Levitt, Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia The Journal of Neuroscience. ,vol. 22, pp. 2718- 2729 ,(2002) , 10.1523/JNEUROSCI.22-07-02718.2002
Florian Stadler, Gabriele Kolb, Lothar Rubusch, Stephen P. Baker, Edward G. Jones, Schahram Akbarian, Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain Journal of Neurochemistry. ,vol. 94, pp. 324- 336 ,(2005) , 10.1111/J.1471-4159.2005.03190.X
Shruti N. Mitkus, Joel E. Kleinman, Daniel R. Weinberger, Barbara K. Lipska, Thomas M. Hyde, Shiny V. Mathew, Robert. Fatula, Functional genomics in postmortem human brain: Abnormalities in a DISC1 molecular pathway in schizophrenia Dialogues in clinical neuroscience. ,vol. 8, pp. 353- 357 ,(2006)
Masayoshi Iizuka, M Mitchell Smith, Functional consequences of histone modifications. Current Opinion in Genetics & Development. ,vol. 13, pp. 154- 160 ,(2003) , 10.1016/S0959-437X(03)00020-0